158 related articles for article (PubMed ID: 22236886)
1. [Systemic therapy for advanced endometrial cancer].
Tazi Y; Pautier P; Lhommé C
Bull Cancer; 2012 Jan; 99(1):93-7. PubMed ID: 22236886
[TBL] [Abstract][Full Text] [Related]
2. [Systemic therapy for advanced endometrial cancer].
Pautier P; Pommeret F
Bull Cancer; 2017 Dec; 104(12):1046-1053. PubMed ID: 29157555
[TBL] [Abstract][Full Text] [Related]
3. Medical therapy of endometrial cancer: current status and promising novel treatments.
Hill EK; Dizon DS
Drugs; 2012 Mar; 72(5):705-13. PubMed ID: 22439671
[TBL] [Abstract][Full Text] [Related]
4. Recent advances in systemic therapy for advanced endometrial cancer.
Tsoref D; Oza AM
Curr Opin Oncol; 2011 Sep; 23(5):494-500. PubMed ID: 21673575
[TBL] [Abstract][Full Text] [Related]
5. Endometrial cancer-targeted therapies myth or reality? Review of current targeted treatments.
Lheureux S; Oza AM
Eur J Cancer; 2016 May; 59():99-108. PubMed ID: 27017291
[TBL] [Abstract][Full Text] [Related]
6. Update on the chemotherapeutic management of endometrial cancer.
Bregar A; Robison K; Dizon DS
Clin Adv Hematol Oncol; 2014 Oct; 12(10):659-65. PubMed ID: 25658891
[TBL] [Abstract][Full Text] [Related]
7. Developments in the systemic treatment of endometrial cancer.
Mountzios G; Pectasides D; Bournakis E; Pectasides E; Bozas G; Dimopoulos MA; Papadimitriou CA
Crit Rev Oncol Hematol; 2011 Sep; 79(3):278-92. PubMed ID: 20833559
[TBL] [Abstract][Full Text] [Related]
8. [Targeted therapies and radiation therapy in non-small cell lung cancer].
Rivera S; Quéro L; Wong Hee Kam S; Maylin C; Deutsch E; Hennequin C
Cancer Radiother; 2011 Oct; 15(6-7):527-35. PubMed ID: 21885318
[TBL] [Abstract][Full Text] [Related]
9. [The validity of chemotherapy in the treatment of endometrial cancer].
Fehr MK; Streich MS
Gynakol Geburtshilfliche Rundsch; 2006; 46(1-2):34-8. PubMed ID: 16452818
[TBL] [Abstract][Full Text] [Related]
10. [Hormonal therapy and chemotherapy of endometrial cancer].
Krauss T; Huschmand H; Hinney B; Viereck V; Emons G
Zentralbl Gynakol; 2002 Jan; 124(1):45-50. PubMed ID: 11873314
[TBL] [Abstract][Full Text] [Related]
11. Targeted agents in ovarian cancer.
Kristedja TS; Morgan RJ; Cristea M
Womens Health (Lond); 2010 Sep; 6(5):679-94. PubMed ID: 20887168
[TBL] [Abstract][Full Text] [Related]
12. New Targeted Agents in Endometrial Cancer: Are We Really Making Progress?
Rodriguez-Freixinos V; Karakasis K; Oza AM
Curr Oncol Rep; 2016 Apr; 18(4):23. PubMed ID: 26922329
[TBL] [Abstract][Full Text] [Related]
13. Combination effects of paclitaxel with signaling inhibitors in endometrial cancer cells.
Xu C; Li X; Li T; Wang X; Yang Y; Xiao L; Shen H
Asian Pac J Cancer Prev; 2011; 12(11):2951-7. PubMed ID: 22393970
[TBL] [Abstract][Full Text] [Related]
14. Systemic therapy in metastatic or recurrent endometrial cancer.
Pectasides D; Pectasides E; Economopoulos T
Cancer Treat Rev; 2007 Apr; 33(2):177-90. PubMed ID: 17196749
[TBL] [Abstract][Full Text] [Related]
15. Current treatment of metastatic endometrial cancer.
Temkin SM; Fleming G
Cancer Control; 2009 Jan; 16(1):38-45. PubMed ID: 19078928
[TBL] [Abstract][Full Text] [Related]
16. Hormonal treatment of endometrial cancer.
Emons G; Heyl W
J Cancer Res Clin Oncol; 2000 Nov; 126(11):619-23. PubMed ID: 11079725
[TBL] [Abstract][Full Text] [Related]
17. mTOR inhibitors and their clinical application in cervical, endometrial and ovarian cancers: a critical review.
Husseinzadeh N; Husseinzadeh HD
Gynecol Oncol; 2014 May; 133(2):375-81. PubMed ID: 24556063
[TBL] [Abstract][Full Text] [Related]
18. Novel strategies for systemic treatment of endometrial cancer.
Elit L; Hirte H
Expert Opin Investig Drugs; 2000 Dec; 9(12):2831-53. PubMed ID: 11093356
[TBL] [Abstract][Full Text] [Related]
19. Targeting angiogenesis in endometrial cancer - new agents for tailored treatments.
Papa A; Zaccarelli E; Caruso D; Vici P; Benedetti Panici P; Tomao F
Expert Opin Investig Drugs; 2016; 25(1):31-49. PubMed ID: 26560489
[TBL] [Abstract][Full Text] [Related]
20. An update on the current pharmacotherapy for endometrial cancer.
de Haydu C; Black JD; Schwab CL; English DP; Santin AD
Expert Opin Pharmacother; 2016; 17(4):489-99. PubMed ID: 26629895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]